Login / Signup
Mónica Kafati
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Tyrosine Kinase
Chronic Lymphocytic Leukemia
Rheumatoid Arthritis Patients
Ejection Fraction
Top Venues
Clinical rheumatology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Marta Novella Navarro
,
Virginia Ruiz-Esquide
,
Natalia López-Juanes
,
Chafik Alejandro Chacur
,
Irene Monjo Henry
,
Laura Nuño
,
Diana Peiteado
,
Alejandro Villalba
,
Elisa Fernández-Fernandez
,
María Sanz-Jardón
,
Mónica Kafati
,
Raimon Sanmartí
,
Chamaida Plasencia-Rodriguez
,
Alejandro Balsa
Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.
Clinical rheumatology
43 (9) (2024)
Marta Novella Navarro
,
Virginia Ruiz-Esquide
,
Natalia López-Juanes
,
Chafik Alejandro Chacur
,
Irene Monjo Henry
,
Laura Nuño
,
Diana Peiteado
,
Alejandro Villalba
,
Elisa Fernández-Fernandez
,
María Sanz-Jardón
,
Mónica Kafati
,
Raimon Sanmartí
,
Chamaida Plasencia-Rodriguez
,
Alejandro Balsa
Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.
Clinical rheumatology
43 (9) (2024)
Marta Novella Navarro
,
Virginia Ruiz-Esquide
,
Natalia López-Juanes
,
Chafik Alejandro Chacur
,
Irene Monjo Henry
,
Laura Nuño
,
Diana Peiteado
,
Alejandro Villalba
,
Elisa Fernández-Fernandez
,
María Sanz-Jardón
,
Mónica Kafati
,
Raimon Sanmartí
,
Chamaida Plasencia-Rodriguez
,
Alejandro Balsa
Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.
Clinical rheumatology
43 (9) (2024)
Marta Novella Navarro
,
Virginia Ruiz-Esquide
,
Natalia López-Juanes
,
Chafik Alejandro Chacur
,
Irene Monjo Henry
,
Laura Nuño
,
Diana Peiteado
,
Alejandro Villalba
,
Elisa Fernández-Fernandez
,
María Sanz-Jardón
,
Mónica Kafati
,
Raimon Sanmartí
,
Chamaida Plasencia-Rodriguez
,
Alejandro Balsa
Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.
Clinical rheumatology
(2024)